Navigation Links
NPS Pharmaceuticals Reports 2007 Financial Results
Date:3/13/2008

ceuticals is developing specialty therapeutics for gastrointestinal and endocrine disorders with high unmet medical need. The company is currently advancing two late-stage programs: GATTEX(TM) (teduglutide) is in Phase 3 clinical development for intestinal failure associated with short bowel syndrome and NPSP558 (parathyroid hormone 1-84 [rDNA origin] injection) is in Phase 2 clinical development as a hormone therapy for hypoparathyroidism. NPS has also completed a Phase 3 osteoporosis study for PREOS(R) (parathyroid hormone 1-84 [rDNA origin] injection). NPS complements its internal programs with strategic partnerships with Amgen, GlaxoSmithKline, Kirin, and Nycomed. Additional information is available at http://www.npsp.com.

Statements made in this press release, which are not historical in nature, constitute forward-looking statements for purposes of the safe harbor provided by the Private Securities Litigation Reform Act of 1995. These statements are based on the company's current expectations and beliefs and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Risks associated to NPS's business include, but are not limited to, the risk of successfully executing its preclinical and clinical studies and gaining marketing approvals for GATTEX and NPSP558, the risks associated with the company's auction-rate securities, the risk that the steps NPS has taken or is taking to address the material weakness will be adequate or that future material weaknesses or control deficiencies will be identified, as well as other factors expressed in NPS's periodic filings with the U.S. Securities and Exchange Commission, including its Annual Report on Form 10-K and Form 10-Qs. All information in this press release is as of the date of this release and NPS undertakes no duty to update this information.


'/>"/>

SOURCE NPS Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Trubion Pharmaceuticals Inc. Reports Fourth-Quarter and Year-Ended 2007 Financial Results and Provides 2008 Financial Outlook
2. ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2007 Financial Results
3. Keryx Biopharmaceuticals to Present at the Cowen and Company 28th Annual Health Care Conference
4. Nventa Biopharmaceuticals Reports Full Year 2007 and Fourth Quarter Financial Results
5. Sagent Pharmaceuticals Launches Cefazolin for Injection, USP
6. Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences
7. Memory Pharmaceuticals Refocuses to Advance Development and Clinical Programs
8. Anadys Pharmaceuticals to Present at the Cowen and Company Healthcare Conference
9. Onyx Pharmaceuticals to Present at Cowen and Company Health Care Conference
10. Indevus Pharmaceuticals to Present at Cowen and Company 28th Annual Health Care Conference
11. VIA Pharmaceuticals to Present at Cowen and Company 28th Annual Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... ... September 01, 2015 , ... GenoCAD, a ... groundbreaking new version of its flagship DNA design platform, which has been enhanced ... sequences into numerous genetic parts, which in turn can be recombined using specific ...
(Date:8/31/2015)... ... August 31, 2015 , ... ... because of its properties such as low carbon footprints and compostability. These properties ... of petroleum based plastics. On the basis of applications, the market for biodegradable ...
(Date:8/31/2015)... , Aug. 31, 2015 Research and Markets ... "Israel Biomedical Sensors Market - Growth, Trends & ... The Israel Biomedical Sensors market is estimated at ... over the period 2014-2020 The near future ... genetic formulation of each individual. These sensors can be ...
(Date:8/31/2015)... Mass. , Aug. 31, 2015  RXi ... company focused on discovering and developing innovative therapies ... today announced that the 30-day review period following ... (IND) for ocular indications with the U.S. Food ... IND is now active. Logo ...
Breaking Biology Technology:GenoCAD Releases Combinatorial Design Tool to Optimize Protein Expression and Streamline DNA Synthesis Orders 2Biodegradable Plastics Market Growing at 10.8% CAGR to 2020 2Biodegradable Plastics Market Growing at 10.8% CAGR to 2020 3Biodegradable Plastics Market Growing at 10.8% CAGR to 2020 4Biodegradable Plastics Market Growing at 10.8% CAGR to 2020 5Israel Biomedical Sensors Market 2015 - Growth, Trends & Forecasts to 2020 2RXi Pharmaceuticals Announces Advancements in its Ophthalmology Clinical Program with RXI-109 2RXi Pharmaceuticals Announces Advancements in its Ophthalmology Clinical Program with RXI-109 3RXi Pharmaceuticals Announces Advancements in its Ophthalmology Clinical Program with RXI-109 4
... major obstacle in producing transistors from networks of carbon ... print circuits on plastic sheets for applications including flexible ... aircraft to monitor crack formation. , The so-called "nanonet" ... overlapping in a fishnet-like structure - has been plagued ...
... or the Company), (Nasdaq: ERES ), a ... and other services to the,pharmaceutical, biotechnology, medical device ... Keith D. Schneck as Executive Vice,President and Chief ... Schneck joins eRT with over 30 years of ...
... 8%, - Non-GAAP Operating Earnings Down 6%, GAAP Operating ... Non-GAAP Diluted EPS Down 2%, GAAP Diluted EPS Down 19%, ... today reported third fiscal quarter 2008 revenues of,$244.4 million, representing ... third quarter of fiscal year 2007. Sales grew for both,industrial ...
Cached Biology Technology:'Nanonet' circuits closer to making flexible electronics reality 2'Nanonet' circuits closer to making flexible electronics reality 3'Nanonet' circuits closer to making flexible electronics reality 4eResearchTechnology Names New Chief Financial Officer 2eResearchTechnology Names New Chief Financial Officer 3Varian, Inc. Reports Third Quarter 2008 Results 2Varian, Inc. Reports Third Quarter 2008 Results 3Varian, Inc. Reports Third Quarter 2008 Results 4Varian, Inc. Reports Third Quarter 2008 Results 5Varian, Inc. Reports Third Quarter 2008 Results 6Varian, Inc. Reports Third Quarter 2008 Results 7Varian, Inc. Reports Third Quarter 2008 Results 8Varian, Inc. Reports Third Quarter 2008 Results 9Varian, Inc. Reports Third Quarter 2008 Results 10Varian, Inc. Reports Third Quarter 2008 Results 11Varian, Inc. Reports Third Quarter 2008 Results 12Varian, Inc. Reports Third Quarter 2008 Results 13Varian, Inc. Reports Third Quarter 2008 Results 14Varian, Inc. Reports Third Quarter 2008 Results 15Varian, Inc. Reports Third Quarter 2008 Results 16Varian, Inc. Reports Third Quarter 2008 Results 17Varian, Inc. Reports Third Quarter 2008 Results 18Varian, Inc. Reports Third Quarter 2008 Results 19Varian, Inc. Reports Third Quarter 2008 Results 20Varian, Inc. Reports Third Quarter 2008 Results 21Varian, Inc. Reports Third Quarter 2008 Results 22Varian, Inc. Reports Third Quarter 2008 Results 23Varian, Inc. Reports Third Quarter 2008 Results 24Varian, Inc. Reports Third Quarter 2008 Results 25
(Date:8/12/2015)... Aug. 12, 2015  Synaptics Inc. (NASDAQ: ... solutions, today announced that four of its fingerprint ... have officially been named FIDO Certified™ by the ... the certification, Synaptics, Natural ID™ fingerprint solutions are ... Framework (UAF) standard and are interoperable among other ...
(Date:8/6/2015)... TELTOW, Germany , August 6, 2015 ... SensoMotoric Instruments (SMI) shows the world,s first ... based on Epson,s Moverio BT-200 see-through head mounted ... this new solution, unprecedented quality and efficiency is brought ... context-sensitive displays. For the first time, professionals and researchers ...
(Date:8/4/2015)... , Aug. 04, 2015 ... http://www.researchandmarkets.com/research/nvh7k2/digital_forensics ) has announced the addition of ... (Hardware, Software, and Service), Sub-Segment (Computer Forensics, ... Forensics), Tool Types, Service, Vertical and Region ... to their offering. By Component ...
Breaking Biology News(10 mins):Synaptics Announces FIDO Certification of Natural ID Fingerprint Solutions 2Synaptics Announces FIDO Certification of Natural ID Fingerprint Solutions 3SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 2SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 3Digital Forensics Market - The Market Represents a Compound Annual Growth Rate (CAGR) of 11.3% From 2015 to 2020 2
... University professor is helping students improve their confidence ... learning. Candice Shoemaker, professor of horticulture, has ... and self-efficacy. Self-efficacy involves student confidence in understanding ... learning and achievement. Shoemaker,s published research appeared in ...
... University of Guam ecologist Thomas Marler recently mobilized efforts ... eruption of Mount Pinatubo, Philippines. "My interest was sparked ... was so powerful it changed global climate, yet after ... ecosystem had not been studied," said Marler. ...
... of all women scientists and one-quarter of male scientists at ... them from having as many children as they had wanted, ... Methodist University (SMU). The study, "Scientists Want More ... and Anne Lincoln of SMU and appears in the current ...
Cached Biology News:Finding their way: Study shows connection between academic direction and student learning 2Finding their way: Study shows connection between academic direction and student learning 3Guam researcher studies Mount Pinatubo ecosystem recovery 2Many top US scientists wish they had more children 2Many top US scientists wish they had more children 3
... data collection and automation that is controlled from ... Excel , Pre-configured library of interfaces for ... can be added and configured by the user ... into one spreadsheet , Allows for ...
...
Peptide-affinity Purified Polyclonal Antibody to MAML1 / Mastermind Peptide with sequence VLPTCPMAEFALPR, from N Terminus of the protein sequence according to NP_055572....
One unit is equal to 10Kb (insert DNA + vector). The final cost will increase or decrease according to the final assembled genome size. The price does not include genome annotation....
Biology Products: